Home/Filings/4/0000950170-24-000345
4//SEC Filing

Havencrest Healthcare Partners, L.P. 4

Accession 0000950170-24-000345

CIK 0001799191other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 5:01 PM ET

Size

43.9 KB

Accession

0000950170-24-000345

Insider Transaction Report

Form 4
Period: 2023-12-28
TOI HC I, LLC
10% Owner
Transactions
  • Other

    Common stock

    2023-12-284,561,05012,801,821 total(indirect: See footnote)
  • Other

    Common stock

    2023-12-283,999,9988,881,823 total(indirect: See footnote)
Transactions
  • Other

    Common stock

    2023-12-284,561,05012,801,821 total(indirect: See footnote)
  • Other

    Common stock

    2023-12-283,999,9988,881,823 total(indirect: See footnote)
Transactions
  • Other

    Common stock

    2023-12-284,561,05012,801,821 total(indirect: See footnote)
  • Other

    Common stock

    2023-12-283,999,9988,881,823 total(indirect: See footnote)
Footnotes (3)
  • [F1]On December 28, 2023, TOI HC I, LLC distributed an aggregate of 4,561,050 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the "TOI HC I Distribution"). Immediately following the TOI HC I Distribution, Havencrest Healthcare Partners GP, LLC (the "General Partner") was the record holder of 3,999,998 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.
  • [F2]Also on December 28, 2023, following the TOI HC I Distribution, the General Partner, on behalf of Havencrest Healthcare Partners, L.P., made a further pro-rata in-kind distribution of the 3,999,998 shares Havencrest Healthcare Partners, L.P. received in the TOI HC I Distribution to Havencrest Healthcare Partners, L.P.'s limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the "Havencrest LP Distribution"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 80,000 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P.
  • [F3](Continued from footnote 2) Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001705748

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:01 PM ET
Size
43.9 KB